PATHOLOGIC STAGE IIIA CUTANEOUS MELANOMA AJCC V8
Clinical trials for PATHOLOGIC STAGE IIIA CUTANEOUS MELANOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new PATHOLOGIC STAGE IIIA CUTANEOUS MELANOMA AJCC V8 trials appear
Sign up with your email to follow new studies for PATHOLOGIC STAGE IIIA CUTANEOUS MELANOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Common cholesterol drug may block melanoma spread in High-Risk patients
Prevention OngoingThis study tests whether atorvastatin, a common cholesterol medication, can prevent melanoma from returning or spreading in people who have had high-risk melanoma surgically removed. About 150 adults with stage IIA, IIB, or IIIA melanoma are participating. The goal is to see if a…
Matched conditions: PATHOLOGIC STAGE IIIA CUTANEOUS MELANOMA AJCC V8
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Prevention
Last updated Apr 29, 2026 03:08 UTC
-
Facebook groups could boost skin cancer screening in young patients and their families
Knowledge-focused OngoingThis study looks at whether a private Facebook group can help young adults (ages 18-39) diagnosed with early-stage melanoma and their close family members do more thorough skin checks and protect themselves from the sun. About 1,160 participants will join either a melanoma-focuse…
Matched conditions: PATHOLOGIC STAGE IIIA CUTANEOUS MELANOMA AJCC V8
Phase: NA • Sponsor: Rutgers, The State University of New Jersey • Aim: Knowledge-focused
Last updated Apr 29, 2026 03:08 UTC